Nancy Torres
Pfizer (United States)(US)Pearl River Community College(US)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Protein Kinase Regulation and GTPase Signaling, Carbohydrate Chemistry and Synthesis, Microbial Natural Products and Biosynthesis, Synthesis and biological activity
Most-Cited Works
- → Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment(2008)42 cited
- → Hydrophobic Acetal and Ketal Derivatives of Mannopeptimycin-α and Desmethylhexahydromannopeptimycin-α: Semisynthetic Glycopeptides with Potent Activity Against Gram-Positive Bacteria(2004)35 cited
- → Non-hinge-binding pyrazolo[1,5-a]pyrimidines as potent B-Raf kinase inhibitors(2009)35 cited
- → Synthesis and activity of novel benzoxazole derivatives of mannopeptimycin glycopeptide antibiotics(2003)33 cited
- → Novel pyrazolopyrimidines as highly potent B-Raf inhibitors(2009)30 cited
- → Synthesis and evaluation of 4-Anilino-6,7-dialkoxy-3-quinolinecarbonitriles as inhibitors of kinases of the Ras-MAPK signaling cascade(2003)28 cited
- → Discovery of highly potent and selective type I B-Raf kinase inhibitors(2009)25 cited
- → Synthesis and evaluation of ether and halogenated derivatives of mannopeptimycin glycopeptide antibiotics(2003)24 cited
- → Novel ether derivatives of mannopeptimycin glycopeptide antibiotic(2003)20 cited
- → Indazolylpyrazolopyrimidine as Highly Potent B-Raf Inhibitors with in Vivo Activity(2010)16 cited